middle.news
INOVIQ Defends Lab Study Claim of 88% Cancer Cell Kill Rate
6:01pm on Monday 23rd of June, 2025 AEST
•
Healthcare
Read Story
INOVIQ Defends Lab Study Claim of 88% Cancer Cell Kill Rate
6:01pm on Monday 23rd of June, 2025 AEST
Key Points
INOVIQ confirms 88% cancer cell death in lab-based in vitro studies
Study conducted in-house with ongoing validation at Peter MacCallum Cancer Institute
Company justifies use of 'treatment' and forward-looking statements despite early research stage
Detailed statistical analysis supports significance of results
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inoviq (ASX:IIQ)
OPEN ARTICLE